Summary
Updated Aug 30, 2026
Lawrence A. Kenyon is Chief Financial Officer, Director of Outlook Therapeutics, Inc. (OTLK). 2 SEC Form 4 filings on record, most recently on 14 August 2026.
Recent Transactions
1Every recent SEC Form 4 transaction Lawrence A. Kenyon has reported, most recent first.
Other Insiders Active in the Same Stocks
Insiders who reported open-market trades in the last 12 months at the companies Lawrence A. Kenyon files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Ghiath M. Sukhtian - $7.50M of OTLK open-market activity in the last 12 months
- Kurt J. Hilzinger - $177K of OTLK open-market activity in the last 12 months
- Faisal Ghiath Sukhtian - $150K of OTLK open-market activity in the last 12 months
- Yezan Munther Haddadin - $39K of OTLK open-market activity in the last 12 months
- Randy H. Thurman - $2K of OTLK open-market activity in the last 12 months
- Robert Charles Jahr - of OTLK open-market activity in the last 12 months
More Notable Insiders
Other corporate insiders with significant SEC Form 4 track records on InsiderAlpha:
Frequently Asked Questions
Who is Lawrence A. Kenyon?
Lawrence A. Kenyon is a corporate insider, tracked as Chief Financial Officer, Director of Outlook Therapeutics, Inc. (OTLK). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Lawrence A. Kenyon submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Has Lawrence A. Kenyon been buying or selling stock?
Recorded transactions: 2 open-market purchases and 0 open-market sales across all tracked filings.
Where can I see all of Lawrence A. Kenyon's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Learn More
Follow Lawrence A. Kenyon and every insider like them
A free account opens the full scored daily plan and every past day, a watchlist for any ticker, and 3 months of price history on every company page. No card.
Free plan available · Paid plans start with a 7-day free trial
